Company intelligence / Profile preview

Provis Biolabs

Hyderabad, Telangana, Indiaprovisbiolabs.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Provis Biolabs has commercialized over ten premium animal-origin-free bioreagent products since its founding in late 2019. The company supports global pharmaceutical and biopharmaceutical R&D through GMP-certified manufacturing facilities. It recently expanded into the US market with a focus on high-quality, ethically sourced reagents.

Therapeutic areas: OncologyOther
Modalities: Recombinant proteins/enzymesAnimal origin-free bioreagentsBioAPIs (biological active pharmaceutical ingredients)Therapeutic enzymesSodium hyaluronateEndonuclease for bio-manufacturing applications
Industry: Contract Manufacturing Organization

Drug pipeline

4 assets

l-asparaginase

Commercial

Indications: Acute lymphoblastic leukemia

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Provis Biolabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Provis Biolabs.

Explore the full profile